Realta Investment Advisors Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Realta Investment Advisors boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 29.4% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,476 shares of the healthcare conglomerate’s stock after acquiring an additional 335 shares during the quarter. Realta Investment Advisors’ holdings in UnitedHealth Group were worth $461,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Wealthcare Advisory Partners LLC boosted its holdings in UnitedHealth Group by 63.7% during the 2nd quarter. Wealthcare Advisory Partners LLC now owns 8,535 shares of the healthcare conglomerate’s stock valued at $2,663,000 after acquiring an additional 3,320 shares during the period. Tandem Investment Partners LLC lifted its holdings in shares of UnitedHealth Group by 21.8% in the 2nd quarter. Tandem Investment Partners LLC now owns 1,397 shares of the healthcare conglomerate’s stock worth $436,000 after buying an additional 250 shares during the period. Hill Island Financial LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth $215,000. BridgePort Financial Solutions LLC lifted its holdings in shares of UnitedHealth Group by 8.7% in the 2nd quarter. BridgePort Financial Solutions LLC now owns 1,669 shares of the healthcare conglomerate’s stock worth $521,000 after buying an additional 133 shares during the period. Finally, Checchi Capital Advisers LLC lifted its holdings in shares of UnitedHealth Group by 29.0% in the 2nd quarter. Checchi Capital Advisers LLC now owns 22,816 shares of the healthcare conglomerate’s stock worth $7,118,000 after buying an additional 5,123 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.8%

Shares of NYSE:UNH opened at $360.17 on Friday. The business’s 50-day moving average is $307.84 and its 200 day moving average is $354.55. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the prior year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on UNH shares. Truist Financial upped their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. KeyCorp reduced their price target on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Morgan Stanley boosted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Finally, Bank of America boosted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.